Search Non-Antibody Products
|
|
|
|
|
Non-antibody Products (Kits, Proteins, Microbial Antigens, Tissues, Services, etc.) - Page 2 of 6,058
| Name |
Description |
Size |
Catalog # |
Supplier |
|
| AT 56 |
Orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 µM, IC50 = 95 µM). Inhibits the production of PGD2 from PGH2 in vitro, with no effect on PGE2 or PGF2alpha production. Minimum Purity: > 99% |
10mg |
3531 |
 TOCRIS BIOSCIENCE |
More Info
|
| AT 56 |
Orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 µM, IC50 = 95 µM). Inhibits the production of PGD2 from PGH2 in vitro, with no effect on PGE2 or PGF2alpha production. Minimum Purity: > 99% |
50mg |
3531 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 582941 |
Selective alpha7 nAChR partial agonist; exhibits high affinity for both rat and human alpha7 receptors (Ki values are 10.8 and 16.7 nM respectively). Displays ~15-fold selectivity for alpha7 over 5-HT3 receptors (Ki = 150 nM for 5-HT3). Minimum Pu... |
10mg |
4341 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 582941 |
Selective alpha7 nAChR partial agonist; exhibits high affinity for both rat and human alpha7 receptors (Ki values are 10.8 and 16.7 nM respectively). Displays ~15-fold selectivity for alpha7 over 5-HT3 receptors (Ki = 150 nM for 5-HT3). Minimum Pu... |
50mg |
4341 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 605240 |
PI 3-Kinase Inhibitor |
10 mg |
3578/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 605240 |
PI 3-Kinase Inhibitor |
50 mg |
3578/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 605240 |
Potent and selective inhibitor of PI 3-kinase gamma (PI3Kgamma) (IC50 = 8 nM). Displays 30-fold selectivity over PI3Kdelta and PI3Kbeta and 7.5-fold selectivity over PI3Kalpha. Suppresses the progression of joint inflammation and damage in both ly... |
10mg |
3578 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 605240 |
Potent and selective inhibitor of PI 3-kinase gamma (PI3Kgamma) (IC50 = 8 nM). Displays 30-fold selectivity over PI3Kdelta and PI3Kbeta and 7.5-fold selectivity over PI3Kalpha. Suppresses the progression of joint inflammation and damage in both ly... |
50mg |
3578 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 740003 |
P2X Receptor Antagonist |
10 mg |
3701/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 740003 |
P2X Receptor Antagonist |
50 mg |
3701/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 740003 |
Potent, selective and competitive P2X7 receptor antagonist (IC50 values are 18 and 40 nM for rat and human receptors respectively). Displays selectivity over a variety of P2X and P2Y receptors up to a concentration of 100 µM. Reduces nocicep... |
10mg |
3701 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 740003 |
Potent, selective and competitive P2X7 receptor antagonist (IC50 values are 18 and 40 nM for rat and human receptors respectively). Displays selectivity over a variety of P2X and P2Y receptors up to a concentration of 100 µM. Reduces nocicep... |
50mg |
3701 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 769662 |
AMPK Activator |
10 mg |
3336/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 769662 |
AMPK Activator |
50 mg |
3336/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 769662 |
Potent, reversible AMP-activated protein kinase (AMPK) activator (EC50 = 0.8 µM) that displays selectivity towards beta1 subunit-containing heterotrimers. Inhibits fatty acid synthesis (IC50 = 3.2 µM) and decreases plasma glucose and t... |
10mg |
3336 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 769662 |
Potent, reversible AMP-activated protein kinase (AMPK) activator (EC50 = 0.8 µM) that displays selectivity towards beta1 subunit-containing heterotrimers. Inhibits fatty acid synthesis (IC50 = 3.2 µM) and decreases plasma glucose and t... |
50mg |
3336 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 803467 |
n/a |
10 mg |
2976/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 803467 |
n/a |
50 mg |
2976/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 803467 |
Selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively). Shows no significant activity against TRPV1, P2X2/3, CaV2.2 and KCNQ2/3 channels. Anti... |
10mg |
2976 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 803467 |
Selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively). Shows no significant activity against TRPV1, P2X2/3, CaV2.2 and KCNQ2/3 channels. Anti... |
50mg |
2976 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 80426 |
Adrenergic alpha-2 Receptor Antagonist |
10 mg |
2341/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 80426 |
Adrenergic alpha-2 Receptor Antagonist |
50 mg |
2341/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 83-01 |
A selective inhibitor of TGF-beta type I receptor ALK5 kinase, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 (IC50 values are 12, 45 and 7.5 nM respectively). Blocks phosphorylation of Smad2 and inhibits TGF-beta-induced epithe... |
1 mg |
1725-1 |
 BIOVISION, INC. |
More Info
|
| A 83-01 |
TGF-beta Receptor Inhibitor |
10 mg |
2939/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 83-01 |
TGF-beta Receptor Inhibitor |
50 mg |
2939/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 83-01 |
Selective inhibitor of TGF-beta type I receptor ALK5 kinase, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 (IC50 values are 12, 45 and 7.5 nM respectively). Blocks phosphorylation of Smad2 and inhibits TGF-beta-induced epitheli... |
10mg |
2939 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 83-01 |
Selective inhibitor of TGF-beta type I receptor ALK5 kinase, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 (IC50 values are 12, 45 and 7.5 nM respectively). Blocks phosphorylation of Smad2 and inhibits TGF-beta-induced epitheli... |
50mg |
2939 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 839977 |
P2X Receptor Antagonist |
10 mg |
4232/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 839977 |
P2X Receptor Antagonist |
50 mg |
4232/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 839977 |
Potent P2X7 antagonist; blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20, 42 and 150 nM respectively). Displays antinociceptive effects in rat and mice models of inflammatory pain. CNS penet... |
10mg |
4232 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 839977 |
Potent P2X7 antagonist; blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20, 42 and 150 nM respectively). Displays antinociceptive effects in rat and mice models of inflammatory pain. CNS penet... |
50mg |
4232 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 841720 |
Group I mGluR Antagonist |
10 mg |
3060/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 841720 |
Group I mGluR Antagonist |
50 mg |
3060/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 841720 |
Potent, non-competitive mGlu1 receptor antagonist that displays 34-fold selectivity over mGlu5 (IC50 values are 10 and 342 nM respectively). Displays no significant activity at a range of other GPCRs, ion channels and transporters. Exhibits analge... |
10mg |
3060 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 841720 |
Potent, non-competitive mGlu1 receptor antagonist that displays 34-fold selectivity over mGlu5 (IC50 values are 10 and 342 nM respectively). Displays no significant activity at a range of other GPCRs, ion channels and transporters. Exhibits analge... |
50mg |
3060 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 887826 |
n/a |
10 mg |
4249/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 887826 |
n/a |
50 mg |
4249/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 887826 |
Potent voltage-dependent NaV1.8 channel blocker (IC50 = 11 nM in recombinant human NaV1.8 channels). Reduces tactile allodynia in neuropathic rat models. 3- and 28-fold more potent at NaV1.8 channels compared to NaV1.2 and NaV1.7 channels respecti... |
10mg |
4249 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 887826 |
Potent voltage-dependent NaV1.8 channel blocker (IC50 = 11 nM in recombinant human NaV1.8 channels). Reduces tactile allodynia in neuropathic rat models. 3- and 28-fold more potent at NaV1.8 channels compared to NaV1.2 and NaV1.7 channels respecti... |
50mg |
4249 |
 TOCRIS BIOSCIENCE |
More Info
|
| 92.1.7 |
n/a |
n/a |
n/a |
VIRCELL S.L. |
More Info
|
| A 922500 |
Acyltransferase Inhibitor |
10 mg |
3587/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 922500 |
Diacylglycerol acyltransferase 1 (DGAT-1) inhibitor (IC50 values are 7 and 24 nM at human and mouse DGAT-1 respectively) that is devoid of activity at DGAT-2, ACAT1 or ACAT2. Induces significant weight loss without altering food intake, and decrea... |
10mg |
3587 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 987306 |
Histamine H4 Receptor Antagonist |
10 mg |
3640/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 987306 |
Histamine H4 Receptor Antagonist |
50 mg |
3640/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 987306 |
Potent histamine H4 receptor antagonist (pKi values are 8.24 and 8.47 in human and rat H4 receptors respectively). Displays 162-fold, 620-fold, and > 1600-fold selectivity over human H3, H1 and H2 receptors. Blocks zymosan-induced neutrophil reflu... |
10mg |
3640 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 987306 |
Potent histamine H4 receptor antagonist (pKi values are 8.24 and 8.47 in human and rat H4 receptors respectively). Displays 162-fold, 620-fold, and > 1600-fold selectivity over human H3, H1 and H2 receptors. Blocks zymosan-induced neutrophil reflu... |
50mg |
3640 |
 TOCRIS BIOSCIENCE |
More Info
|
| A2.01 |
n/a |
n/a |
n/a |
 NIH AIDS RESEARCH & REFERENCE REAGENT PROGRAM |
More Info
|
| A3.01 |
n/a |
n/a |
n/a |
 NIH AIDS RESEARCH & REFERENCE REAGENT PROGRAM |
More Info
|
| A549 |
n/a |
n/a |
n/a |
VIRCELL S.L. |
More Info
|
| A-769662 |
A-769662 Purity is greater than 99%. |
10 mg |
orb60992 |
 BIORBYT LTD. |
More Info
|
Search Non-Antibody Products
|